2024 Q1 Form 10-K Financial Statement
#000109181824000032 Filed on March 29, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $173.5K | $102.0K | |
YoY Change | 20.95% | -19.43% | |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $173.5K | $102.0K | $427.0K |
YoY Change | 20.95% | -19.43% | -19.13% |
Operating Profit | |||
YoY Change | |||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $137.7K | -$102.1K | $4.847M |
YoY Change | -4.0% | -19.36% | -1017.92% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | 0.0% | ||
Net Earnings | $137.7K | -$102.1K | -$4.847M |
YoY Change | -196.0% | -19.35% | 817.92% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | -$0.10 | |
Diluted Earnings Per Share | $0.00 | $0.00 | -$0.10 |
COMMON SHARES | |||
Basic Shares Outstanding | 47.64M shares | 56.14M shares | 49.08M shares |
Diluted Shares Outstanding | 47.64M shares | 49.08M shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $480.00 | $1.180K | $1.180K |
YoY Change | 1100.0% | 1585.71% | 1585.71% |
Cash & Equivalents | $482.00 | $1.180K | $1.180K |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | $0.00 | $0.00 | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $482.00 | $1.180K | $1.180K |
YoY Change | 1020.93% | 1516.44% | 1585.71% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $482.00 | $1.180K | $1.180K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $482.00 | $1.180K | $1.180K |
YoY Change | 1020.93% | 1516.44% | 1585.71% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $58.54K | $12.45K | $12.45K |
YoY Change | 2548.87% | 1560.0% | 1560.0% |
Accrued Expenses | $251.0K | $207.3K | $207.3K |
YoY Change | -84.84% | -86.52% | -86.52% |
Deferred Revenue | $35.80K | $35.80K | |
YoY Change | |||
Short-Term Debt | $237.3K | $154.3K | $154.3K |
YoY Change | 9.45% | -20.3% | -20.3% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $546.8K | $409.9K | $409.9K |
YoY Change | -71.39% | -76.81% | -76.81% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $546.8K | $409.9K | $409.9K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $546.8K | $409.9K | $409.9K |
YoY Change | -71.39% | -76.81% | -76.81% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$95.93M | -$95.79M | |
YoY Change | 5.32% | 5.33% | |
Common Stock | $4.763K | $4.763K | |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$546.3K | -$408.7K | -$408.7K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $482.00 | $1.180K | $1.180K |
YoY Change | 1020.93% | 1516.44% | 1585.71% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $137.7K | -$102.1K | -$4.847M |
YoY Change | -196.0% | -19.35% | 817.92% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$83.69K | -$45.34K | -$165.3K |
YoY Change | 259.92% | 506.96% | 211.76% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | ||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $82.99K | 36.45K | 166.5K |
YoY Change | 257.38% | 389.26% | 213.97% |
NET CHANGE | |||
Cash From Operating Activities | -$83.69K | -45.34K | -165.3K |
Cash From Investing Activities | |||
Cash From Financing Activities | $82.99K | 36.45K | 166.5K |
Net Change In Cash | -$698.00 | -8.890K | 1.110K |
YoY Change | 2226.67% | 44350.0% | -5650.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$83.69K | -$45.34K | -$165.3K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | brvo |
Notes Receivable Related Party
NotesReceivableRelatedParty
|
usd | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001444839 | |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
usd | |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
usd | |
CY2023Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
usd | |
CY2022Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
usd | |
CY2022Q4 | brvo |
Notes Receivable Related Party
NotesReceivableRelatedParty
|
usd | |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023 | brvo |
Rescission With Rpi
RescissionWithRpi
|
usd | |
CY2022 | brvo |
Discontinued Operations
DiscontinuedOperations
|
usd | |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2023 | us-gaap |
Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
|
usd | |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2022 | brvo |
Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
|
usd | |
CY2022 | brvo |
Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
|
usd | |
CY2023Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
usd | |
CY2022Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
usd | |
CY2023Q4 | brvo |
Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
|
usd | |
CY2022Q4 | brvo |
Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
|
usd | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
000-53505 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
BRAVO MULTINATIONAL INCORPORATED | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
WY | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
85-4068651 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2020 General Booth Blvd | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Unit 230 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Virginia Beach | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
VA | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
12802415 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
47641011 | shares |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023 | dei |
Auditor Name
AuditorName
|
BF Borgers CPA PC | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5041 | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Lakewood, CO | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1180 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
73 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42312 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42312 | usd |
CY2023Q4 | us-gaap |
Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
|
2725 | usd |
CY2022Q4 | us-gaap |
Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
|
2725 | usd |
CY2023Q4 | brvo |
Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
|
-418000 | usd |
CY2022Q4 | brvo |
Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
|
-418000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1180 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
73 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
1180 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
73 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
12453 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
750 | usd |
CY2023Q4 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
35800 | usd |
CY2022Q4 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
35800 | usd |
CY2023Q4 | brvo |
Due To Related Parties
DueToRelatedParties
|
154280 | usd |
CY2022Q4 | brvo |
Due To Related Parties
DueToRelatedParties
|
193570 | usd |
CY2023Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
207250 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
1537417 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
409783 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
1767537 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47641010 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47641010 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47641010 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47641010 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4763 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4763 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
95374299 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
89168493 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-95787765 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-90940720 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-408703 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1767464 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1180 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
73 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18071 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8793 | usd |
CY2023 | us-gaap |
Professional Fees
ProfessionalFees
|
158974 | usd |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
44265 | usd |
CY2023 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
250000 | usd |
CY2022 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
475000 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
427045 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
528058 | usd |
CY2023 | brvo |
Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
|
-427045 | usd |
CY2022 | brvo |
Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
|
-528058 | usd |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
4420100 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
4847145 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
528058 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
4847145 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
528058 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
49084847 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
49084847 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47641010 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47641010 | shares |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.10 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.10 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1239506 | usd |
CY2022 | us-gaap |
Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
|
100 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-528058 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1767464 | usd |
CY2023 | brvo |
Merger With Rpi And Share Issuance
MergerWithRpiAndShareIssuance
|
4420000 | usd |
CY2023 | us-gaap |
Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
|
1785906 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4847145 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-408703 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4847145 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-528058 | usd |
CY2023 | brvo |
Discontinued Operations
DiscontinuedOperations
|
4420100 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-40 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
11703 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-16 | usd |
CY2023 | brvo |
Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
|
250000 | usd |
CY2022 | brvo |
Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
|
475000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-165342 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-53034 | usd |
CY2022 | us-gaap |
Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
|
100 | usd |
CY2023 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
166449 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
52914 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
166449 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
53014 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
1107 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-20 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
73 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1180 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
73 | usd |
CY2023 | brvo |
Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
|
1580167 | usd |
CY2023 | brvo |
Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
|
205739 | usd |
CY2023 | brvo |
Net Royalty Percentage
NetRoyaltyPercentage
|
0.15 | pure |
CY2023Q4 | us-gaap |
Area Of Land
AreaOfLand
|
76.63 | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84C_eus-gaap--UseOfEstimates_zD1m1Gbbw1e1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86C_zoO0uNROYVEk">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> | |
CY2023Q4 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
42312 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
42312 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42312 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42312 | usd |
CY2017Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
42312 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42312 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
42312 | usd |
CY2023 | brvo |
Rent Expense
RentExpense
|
0 | usd |
CY2022 | brvo |
Rent Expense
RentExpense
|
0 | usd |
CY2023 | us-gaap |
Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
|
42312 | usd |
CY2023Q4 | brvo |
Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
|
418000 | usd |
CY2022Q4 | brvo |
Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
|
418000 | usd |
CY2023Q4 | brvo |
Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
|
-418000 | usd |
CY2022Q4 | brvo |
Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
|
-418000 | usd |
CY2023Q4 | brvo |
Due To Related Parties
DueToRelatedParties
|
154280 | usd |
CY2022Q4 | brvo |
Due To Related Parties
DueToRelatedParties
|
193570 | usd |
CY2023 | brvo |
Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
|
1720 | usd |
CY2022 | brvo |
Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
|
0 | usd |
CY2023 | brvo |
Filing Fees
FilingFees
|
2795 | usd |
CY2022 | brvo |
Filing Fees
FilingFees
|
0 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q1 | brvo |
Shares Authorized
SharesAuthorized
|
1050000000 | shares |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4420000 | usd |
CY2023Q4 | us-gaap |
Shares Issued
SharesIssued
|
4516667 | shares |
CY2023Q3 | us-gaap |
Shares Issued
SharesIssued
|
8500000 | shares |
CY2023Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4420000 | usd |
CY2023Q4 | brvo |
Share Exchange Agreement Description
ShareExchangeAgreementDescription
|
share exchange agreement was rescinded by all parties and the issued shares were returned. |